The Penn Diabetes Research Center (DRC) participates in the nationwide interdisciplinary program established over three decades ago by the NIDDK to foster research in diabetes and related metabolic disorders. The mission of the Penn DRC is to support and develop successful approaches to the prevention, treatment, and cure of diabetes mellitus. Located at and administered by the University of Pennsylvania, the Penn DRC serves over 110 diabetes-oriented investigators, primarily from Penn's Perelman School of Medicine but also from other Schools within the University as well as collaborating Philadelphia institutions including Thomas Jefferson University, Temple University School of Medicine, the Monell Chemical Senses Center, and the Wistar Institute. The Penn DERC is highly interactive and interdisciplinary, representing many basic science and clinical departments. The Research Base of the Penn DRC is organized in 4 focus groups: 1) Beta Cell Physiology and Pathology;2) Signaling by Insulin and Other Hormones;3) Obesity;and 4) Cardiovascular Metabolism and Complications. The Penn DRC facilitates and supports diabetes research in a variety of ways. Six Biomedical Research Cores facilitate the work of Penn DRC investigators: Functional Genomics Core;Islet Cell Biology Core;Mouse Phenotyping, Physiology, and Metabolism Core;Radioimmunoassay/Biomarkers Core;Transgenic and Chimeric Mouse Core;and Viral Vector Core. Collaborative research and application of emerging technologies to diabetes investigation are further promoted by the Regional Metabolomic Core at Princeton. A Pilot and Feasibility Grant Program that has been highly successful for over three decades serves to nurture new investigators and to foster new initiatives in diabetes research. A broad and intensive Enrichment Program organizes weekly Diabetes and Endocrinology Research seminars, special events, and an annual Spring Diabetes Symposium, all designed to enhance communication and collaboration of Penn DRC investigators while keeping them abreast of the latest discoveries. Penn DRC investigators mentor trainees at every level (undergraduate, predoctoral, and post-doctoral Ph.D., M.D., and combined M.D. /Ph.D), and the Enrichment Program provides a superb environment for training in diabetes research. The Biomedical Cores, Pilot and Feasibility Grant Program, and Enrichment Program are coordinated and publicized by an Administrative Component that governs the DRC. Its organizational structure, including the Director and Associate Director, Executive Committee, Committee of Core Directors, and external as well as internal advisory boards, functions to maintain the diabetes-related research at the Penn DRC at the forefront of biomedical science.

Public Health Relevance

It is estimated that 25.8 million people in the United States (8.3 percent of the population) currently have diabetes, and the rate is higher among the elderly and Hispanics, Native Americans, and African-Americans. The mission of the Penn Diabetes Research Center is to prevent and cure this devastating disease and its complications through interdisciplinary basic and translational research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK019525-37
Application #
8469468
Study Section
Special Emphasis Panel (ZDK1-GRB-S (J1))
Program Officer
Hyde, James F
Project Start
1997-03-01
Project End
2017-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
37
Fiscal Year
2013
Total Cost
$1,821,831
Indirect Cost
$565,801
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Park, Hyeong-Kyu; Ahima, Rexford S (2015) Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 64:24-34
Mulvey, Claire K; McNeill, Ann M; Girman, Cynthia J et al. (2014) Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreatic *-cell function with coronary artery calcification and microalbuminuria in type 2 diabetes. Diabetes Care 37:124-33
Roe, Andrea; Hillman, Jennifer; Butts, Samantha et al. (2014) Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS. J Clin Endocrinol Metab 99:E841-7
Soleimanpour, Scott A; Gupta, Aditi; Bakay, Marina et al. (2014) The diabetes susceptibility gene Clec16a regulates mitophagy. Cell 157:1577-90
Ferguson, Jane F; Mulvey, Claire K; Patel, Parth N et al. (2014) Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers. Mol Nutr Food Res 58:601-13
Tsai, Yu-Cheng; Cooke, Nancy E; Liebhaber, Stephen A (2014) Tissue specific CTCF occupancy and boundary function at the human growth hormone locus. Nucleic Acids Res 42:4906-21
Prenner, Stuart B; Mulvey, Claire K; Ferguson, Jane F et al. (2014) Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides. Atherosclerosis 236:244-50
Lee, Dolim; Le Lay, John; Kaestner, Klaus H (2014) The transcription factor CREB has no non-redundant functions in hepatic glucose metabolism in mice. Diabetologia 57:1242-8
Li, Ming; Li, Changhong; Allen, Aron et al. (2014) Glutamate dehydrogenase: structure, allosteric regulation, and role in insulin homeostasis. Neurochem Res 39:433-45
Naidoo, Nirinjini; Davis, James G; Zhu, Jingxu et al. (2014) Aging and sleep deprivation induce the unfolded protein response in the pancreas: implications for metabolism. Aging Cell 13:131-41

Showing the most recent 10 out of 487 publications